Candidal esophagitis
ICD-10 B37.81 is a billable code used to indicate a diagnosis of candidal esophagitis.
Candidal esophagitis is a fungal infection of the esophagus caused primarily by the overgrowth of Candida species, most commonly Candida albicans. This condition is characterized by inflammation and ulceration of the esophageal mucosa, leading to symptoms such as odynophagia (painful swallowing), dysphagia (difficulty swallowing), and retrosternal pain. It is often seen in immunocompromised patients, including those with HIV/AIDS, cancer, diabetes, or those undergoing immunosuppressive therapy. The diagnosis is typically confirmed through endoscopy, where white plaques or lesions may be observed, and biopsy may be performed to rule out other conditions. Treatment usually involves antifungal medications, such as fluconazole or itraconazole, which are effective in managing the infection. In severe cases, intravenous antifungals may be required. Prompt diagnosis and treatment are crucial to prevent complications such as esophageal perforation or systemic infection.
Detailed endoscopic findings, biopsy results, and treatment plans.
Patients presenting with dysphagia and odynophagia, especially those with a history of immunosuppression.
Ensure that the immunocompromised status is clearly documented to support the diagnosis.
Comprehensive history of the patient's immune status and previous infections.
Patients with recurrent fungal infections or those undergoing treatment for HIV/AIDS.
Document the rationale for antifungal therapy and any previous treatment failures.
Used to diagnose candidal esophagitis in patients presenting with dysphagia.
Endoscopic findings and any biopsies taken must be documented.
Gastroenterologists should ensure that the indication for the procedure is clearly stated.
Common symptoms include painful swallowing (odynophagia), difficulty swallowing (dysphagia), and chest pain. Patients may also experience nausea and vomiting.
